J M Polak

Orton Orthopaedic Hospital, Helsinki, Province of Southern Finland, Finland

Are you J M Polak?

Claim your profile

Publications (569)2321.88 Total impact

  • Source
    Article: Relationship between Neuropeptide lmmuno reactive Nerves and Inflammatory Cells in Adjuvant Arthritic Rats
    [show abstract] [hide abstract]
    ABSTRACT: Konttinen YT, Hukkanen M, Segerberg M, Rees R, Kemppinen P, Sorsa T, Saari H, Polak JM, Santavirta S. Relationship between Neuropeptide Immunoractive Nerves and Inflammatory Cells in Adjuvant Arthritic Rats. Scand J Rheumatol 1992; 21: 55–9. The purpose of this study was to assess the relationship of neuropeptide nerves and inflammatory leukocytes in PVG rats with adjuvant-induced arthritis. Substance P- and calcitonin gene-related peptide (CGRP)-immuno reactive nerves and inflammatory leukocytes were studied, using peroxidase (ABC) andor alkaline phosphatase (APAAP) staining. Inflamed synovial tissue proper was infiltrated with neutrophils, ED1 macrophages and focal accumulations of CD2 T lymphocytes. In such tissue, the relationship between peptide-immuno reactive nerves and inflammatory cells was such that substance P and CGRP nerves were absent in heavily infiltrated villous synovial tissue, whereas healthy synovial tissue and non-inflammatory areas in adjuvant arthritic rats were innervated by substance P and CGRP nerves close to normal synovial tissue resident cells. In order to elucidate an eventual mechanism for lost immuno reactivity, healthy synovial tissue was exposed to chymotrypsin or oxygen derived free radicals (ODFR) in vitro. The former treatment caused total loss of immuno reactivity. These findings suggest that neuropeptides and neuropeptide containing nerves may be destroyed by locally produced proteolytic enzymes and various reactive oxygen species in the vicinity of inflammatory cells.
    07/2009; 21(2):55-59.
  • Article: Bioactive glass-induced osteoblast differentiation: a noninvasive spectroscopic study.
    [show abstract] [hide abstract]
    ABSTRACT: Here, we report on a rapid, noninvasive biophotonics system using Raman spectroscopy to detect real-time biochemical changes in foetal osteoblasts (FOBs) following exposure to 45S5 Bioglass (BG)-conditioned media. Bio-Raman spectroscopy, combined with multivariate statistical analysis techniques (principal component analysis and least squares analysis), was able to noninvasively identify biochemical differences in FOBs cultured for different time periods and between FOBs exposed/or not to BG-conditioned media. Gene and protein expression studies were also performed for known markers of osteoblastic differentiation, namely, alkaline phosphatase, bone sialoprotein, and collagen type I. Quantitative RT-PCR confirmed upregulation of genes associated with osteoblast differentiation after exposure to BG-conditioned media. These results suggest that Raman spectroscopy can noninvasively detect biochemical changes in FOBs associated with differentiation. This technique could have important applications in the field of regenerative medicine by enabling rapid characterization of cell or organoid behavior on novel bioactive scaffolds without damage to either cell or biomaterial.
    Journal of Biomedical Materials Research Part A 08/2008; 86(1):31-40. · 2.63 Impact Factor
  • Article: Immunocytochemical localization of neuron specific enolase in small cell carcinomas and carcinoid tumours of the lung
    [show abstract] [hide abstract]
    ABSTRACT: Carcinoid tumours and small cell carcinomas of the lung share many characteristics with normal neuroendocrine cells. While carcinoid tumours contain many dense-cored neurosecretory granules and are frequently argyrophil, small cell carcinomas are poorly granulated and rarely argyrophil, which casts doubt on their neuroendocrine nature. Immunostaining of the enzyme neuron specific enolase (NSE) was recently used to demonstrate the neuroendocrine components of the lung including nerves and neuroendocrine cells. We therefore used NSE immunostaining to investigate neuroendocrine differentiation in 79 lung tumours, including 18 bronchial carcinoids and 31 small cell carcinomas, and compared these results with those obtained with silver stains. Thirteen of the 18 carcinoids were reactive to silver, all other types being negative. NSE-immunoreactivity occurred in 16 carcinoids and 18 small cell carcinomas. None of the squamous cell carcinomas, large cell anaplastic carcinomas and adenocarcinomas examined showed NSE-immucoreactivity. Radioimmunoassay of extractable NSE from 10 fresh lung tumours correlated well with the immunostaining results, demonstrating large amounts in two small cell carcinomas (334 and 517 ng/mg protein) and three carcinoids (152, 908, and 1143 ng/mg protein). Values were much lower for four squamous cell carcinomas (31–44 ng/mg protein) and one large cell anaplastic carcinoma (30 ng/mg protein) and were accounted for by the presence of NSE-positive nerves and neuroendocrine cells in the surrounding lung. NSE immunostaining is a useful marker of neuroendocrine differentiation in lung tumours and should prove particularly valuable in the diagnosis of small cell anaplastic tumours and their metastases.
    Histopathology 04/2007; 8(2):171 - 181. · 3.08 Impact Factor
  • Article: Enhanced differentiation and mineralization of human fetal osteoblasts on PDLLA containing Bioglass® composite films in the absence of osteogenic supplements
    [show abstract] [hide abstract]
    ABSTRACT: This study investigates the cellular response of fetal osteoblasts to bioactive resorbable composite films consisting of a poly-D,L-lactide (PDLLA) matrix and bioactive glass 45S5 Bioglass® (BG) particles at three different concentrations (0% (PDLLA), 5% (P/BG5), and 40% (P/BG40)). Using scanning electron microscopy (SEM) we observed that cells were less spread and elongated on PDLLA and P/BG5, whereas cells on P/BG40 were elongated but with multiple protrusions spreading over the BG particles. Vinculin immunostaining revealed similar distribution of focal adhesion contacts on all cells independent of substratum, indicating that all materials permitted cell adhesion. However, when differentiation and maturation of fetal osteoblasts was examined, incorporation of 45S5 BG within the PDLLA matrix was found to significantly (p < 0.05) enhance alkaline phosphatase enzymatic activity and osteocalcin protein synthesis compared to tissue culture polystyrene controls and PDLLA alone. Alizarin red staining indicated extracellular matrix mineralization on both P/BG5 and P/BG40, with significantly more bone nodules formed than on PDLLA. Real time RT-PCR revealed that expression of bone sialoprotein was also affected by the BG containing films compared to controls, whereas expression of Collagen Type I was not influenced. By performing these investigations in the absence of osteogenic factors it appears that the incorporation of BG stimulates osteoblast differentiation and mineralization of the extracellular matrix, demonstrating the osteoinductive capacity of the composite. © 2006 Wiley Periodicals, Inc. J Biomed Mater Res, 2006
    Journal of Biomedical Materials Research Part A 03/2007; 80A(4):837 - 851. · 2.63 Impact Factor
  • Article: Enhanced differentiation and mineralization of human fetal osteoblasts on PDLLA containing Bioglass composite films in the absence of osteogenic supplements.
    [show abstract] [hide abstract]
    ABSTRACT: This study investigates the cellular response of fetal osteoblasts to bioactive resorbable composite films consisting of a poly-D,L-lactide (PDLLA) matrix and bioactive glass 45S5 Bioglass (BG) particles at three different concentrations (0% (PDLLA), 5% (P/BG5), and 40% (P/BG40)). Using scanning electron microscopy (SEM) we observed that cells were less spread and elongated on PDLLA and P/BG5, whereas cells on P/BG40 were elongated but with multiple protrusions spreading over the BG particles. Vinculin immunostaining revealed similar distribution of focal adhesion contacts on all cells independent of substratum, indicating that all materials permitted cell adhesion. However, when differentiation and maturation of fetal osteoblasts was examined, incorporation of 45S5 BG within the PDLLA matrix was found to significantly (p < 0.05) enhance alkaline phosphatase enzymatic activity and osteocalcin protein synthesis compared to tissue culture polystyrene controls and PDLLA alone. Alizarin red staining indicated extracellular matrix mineralization on both P/BG5 and P/BG40, with significantly more bone nodules formed than on PDLLA. Real time RT-PCR revealed that expression of bone sialoprotein was also affected by the BG containing films compared to controls, whereas expression of Collagen Type I was not influenced. By performing these investigations in the absence of osteogenic factors it appears that the incorporation of BG stimulates osteoblast differentiation and mineralization of the extracellular matrix, demonstrating the osteoinductive capacity of the composite.
    Journal of Biomedical Materials Research Part A 03/2007; 80(4):837-51. · 2.63 Impact Factor
  • Source
    Article: Biocompatibility of poly-DL-lactic acid (PDLLA) for lung tissue engineering.
    [show abstract] [hide abstract]
    ABSTRACT: This study explores the possibility of growing lung cells on poly-DL-lactic acid (PDLLA) scaffolds, with a view to in future engineer pulmonary tissue for human implantation. As a first step in this process, the ability of PDLLA to maintain the growth of lung epithelium is tested using a robust cell line. Poly-DL-lactic acid has been investigated in two forms, as planar discs and as 3-D foams, and it has been demonstrated that PDLLA is not only nontoxic to pneumocytes but it also actively supports their growth. The initial findings suggest that the material is an appropriate matrix for engineering of distal lung tissue.
    Journal of Biomaterials Applications 11/2006; 21(2):109-18. · 2.08 Impact Factor
  • Source
    Article: Embryonic stem cells and tissue engineering: delivering stem cells to the clinic.
    Journal of the Royal Society of Medicine 09/2005; 98(8):346-50. · 1.41 Impact Factor
  • Source
    Article: Pantoprazole in severe acid-peptic disease: the effectiveness and safety of 5 years' continuous treatment.
    [show abstract] [hide abstract]
    ABSTRACT: This is our final report on the clinical effectiveness and safety of long-term pantoprazole in patients with severe peptic ulcer or reflux disease during continuous treatment for up to 5 years. Patients (n= 150) with peptic ulcer or reflux erosive oesophagitis running an aggressive course or with complications, and refractory to H2-receptor antagonists, were entered into this 5-year programme. Assessment was by serial endoscopy, clinical examination, serum gastrin estimation, gastric mucosal histology and mucosal endocrine cell quantification. Healing results were presented earlier. The estimated rates of remission on maintenance treatment with pantoprazole (n = 115) were 82% at 1 year, 75% at 2 years, 72% at 3 years, 70% at 4 years and 68% at 5 years. Helicobacter pylori infection appeared not to influence the outcome in reflux patients, with roughly two-thirds continuing in remission irrespective of infection. Only four patients had adverse events considered to be definitely related to pantoprazole. Median gastrin levels rose by 1.5-2-fold and were higher in those with H. pylori infection; 13 patients had levels >500 ng/L on at least one occasion, but these high levels were not sustained. Histological changes were more marked in patients infected with H. pylori: chronic gastritis decreased in the antrum and increased in the corpus, which also showed atrophic changes. The total number of endocrine cells in the antrum showed little variation over 60 months but fell by around one-third in the corpus. Long-term treatment with pantoprazole is effective and safe.
    Digestive and Liver Disease 02/2005; 37(1):10-22. · 3.05 Impact Factor
  • Source
    Article: A histological study of the hph-1 mouse mutant: an animal model of phenylketonuria and infantile hypertrophic pyloric stenosis.
    [show abstract] [hide abstract]
    ABSTRACT: To quantify the chronological sequence of changes in the morphology and immunoreactivity for neurotransmitters in the pylorus of an animal model of infantile hypertrophic pyloric stenosis and phenylketonuria. Thirty specimens of pylorus from hph-1 mice and age/sex matched controls (age range: 10-180 days) were examined using conventional histology and immunohistochemistry for a variety of antigens: protein gene product 9.5, a pan neuronal marker; vasoactive intestinal polypeptide; nitric oxide synthase two antigens coalesced to the same inhibitory neurons in humans; substance P, a potent excitatory neurotransmitter; and calcitonin gene related peptide, a neurotransmitter implicated in the somatic afferent innervation of the stomach. The changes in the morphology of the muscle layers were quantified and statistically analysed for each age group (10, 20, 40, 90 and 180 days). Between 10 and 90 days of age, all muscle layers of the hph-1 mice were hypertrophied, for example, 10 days, hph-1 longitudinal muscle mean diameter = 3.4, control = 1.8; hph-1 circular muscle width = 11.5, control = 4.7. The hph-1 mice were significantly smaller during this period (40 days, hph-1 weight = 10 g, control = 25 g). There was no change in the pattern of expression of the antigens examined within the hph-1 mice compared with the controls. Hph-1 mice develop a transient smooth muscle hypertrophy of the pylorus attended by gastric distension and failure to gain weight. These changes resolve as the pyloric muscle hypertrophy resolves.
    Anantomia Histologia Embryologia 07/2004; 33(3):125-30. · 0.90 Impact Factor
  • Source
    Article: The stem cell in orthopaedic surgery.
    Journal of Bone and Joint Surgery - British Volume 04/2004; 86(2):159-64. · 2.83 Impact Factor
  • Source
    Article: Initial observations on the effect of medium composition on the differentiation of murine embryonic stem cells to alveolar type II cells.
    [show abstract] [hide abstract]
    ABSTRACT: The pluripotency and high proliferative index of embryonic stem (ES) cells make them a good potential source of cells for tissue engineering purposes. We have shown that ES cells can be induced to differentiate in vitro into pulmonary epithelial cells (type II pneumocytes) using a serum-free medium designed for the maintenance of mature distal lung epithelial cells in culture (SAGM). However, the resulting cell cultures were heterogeneous. Our aim in this study was to attempt to increase pneumocyte yield and differentiation state by determining which medium components enhance the differentiation of pneumocytes and modifying the medium accordingly. Quantitative RT-PCR was used to measure changes in the expression of a type II pneumocyte-specific gene, surfactant protein C (SPC), in response to alterations in the cell culture medium. Results suggested that most individual SAGM growth factors were inhibitory for type II pneumocyte differentiation, with the largest increases in SPC expression (approximately threefold) being observed upon removal of retinoic acid and triiodothryonine. However, large standard deviations occurred between replicates, illustrating the highly variable nature of ES cell differentiation. Nevertheless, these observations represent an initial step towards achieving directed differentiation of pneumocytes from stem cells that could lead to their purification for tissue engineering purposes.
    Cloning and Stem Cells 02/2004; 6(2):49-56. · 2.66 Impact Factor
  • Article: Scaffolds and biomaterials for tissue engineering: a review of clinical applications.
    A Vats, N S Tolley, J M Polak, J E Gough
    [show abstract] [hide abstract]
    ABSTRACT: Tissue engineering is a multidisciplinary area of research aimed at regeneration of tissues and restoration of organ function. This is achieved through implantation of cells/tissues grown outside the body or by stimulating cells to grow into an implanted matrix. In this short review, we discuss the use of biomaterials, in the form of scaffolds, for tissue engineering and review clinical applications to otorhinolaryngology-head and neck surgery.
    Clinical Otolaryngology 07/2003; 28(3):165-72. · 2.39 Impact Factor
  • Article: Spectroscopic study of human lung epithelial cells (A549) in culture: living cells versus dead cells.
    [show abstract] [hide abstract]
    ABSTRACT: The noninvasive analysis of living cells grown on 3-dimensional scaffold materials is a key point in tissue engineering. In this work we show the capability of Raman spectroscopy for use as a noninvasive method to distinguish cells at different stages of the cell cycle and living cells from dead cells. The spectral differences between cells in different stages of the cell cycle are characterized mainly by variations in DNA vibrations at 782, 788, and 1095 cm(-1). The Raman spectrum of dead human lung derived (A549 line) cells indicates the breakdown of both phosphodiester bonds and DNA bases. The most sensitive peak for identifying dead cells is the 788 cm(-1) peak corresponding to DNA Obond;Pbond;O backbone stretching. The magnitude of this peak is reduced by 80% in the spectrum of dead cells. Changes in protein peaks suggest significant conformational changes; for example, the magnitude of the 1231 cm(-1) peak assigned to random coils is reduced by 63% for dead cells. The sharp peak of phenylalanine at 1005 cm(-1) drops to half, indicating a decrease of stable proteins associated with cell death. The differences in the 1190-1385 cm(-1) spectral region also suggest a decrease in the amount of nucleic acids and proteins. Using curve fitting, we quantify these spectral differences that can be used as markers of cell death.
    Biopolymers 02/2003; 72(4):230-40. · 2.87 Impact Factor
  • Article: Gene expression: a review of clinical applications in otorhinolaryngology-head and neck surgery.
    [show abstract] [hide abstract]
    ABSTRACT: Tissue engineering is a multidisciplinary area of research aimed at regeneration of tissues and restoration of function of organs through implantation of cells/tissues grown outside the body or stimulating cells to grow into implanted matrix. In this short review, we aim to examine current techniques in gene expression analysis and their relevant clinical applications to the field of otorhinolaryngology-head and neck surgery.
    Clinical Otolaryngology 11/2002; 27(5):291-5. · 2.39 Impact Factor
  • Article: Stem cells: sources and applications.
    [show abstract] [hide abstract]
    ABSTRACT: Tissue engineering is a multidisciplinary area of research aimed at regeneration of tissues and restoration of function of organs through implantation of cells/tissues grown outside the body, or stimulating cells to grow into implanted matrix. In this short review, some of the most recent developments in the use of stem cells for tissue repair and regeneration will be discussed. There is no doubt that stem cells derived from adult and embryonic sources hold great therapeutic potential but it is clear that there is still much research required before their use is commonplace. There is much debate over adult versus embryonic stem cells and whether both are required. It is probably too early to disregard one or other of these cell sources. With regard to embryonic stem cells, the major concern relates to the ethics of their creation and the proposed practice of therapeutic cloning.
    Clinical Otolaryngology 09/2002; 27(4):227-32. · 2.39 Impact Factor
  • Article: A quantitative study of the neural changes underlying pyloric stenosis in dogs.
    [show abstract] [hide abstract]
    ABSTRACT: This study aimed to quantify the neural changes in congenital pyloric stenosis in dogs and to study the comparative anatomy between this condition in dogs and that in infantile hypertrophic pyloric stenosis. Eight specimens from the pylorus of dogs with pyloric stenosis and six control specimens were examined using conventional histology and immunohistochemistry for a range of neural antigens. The changes in the proportion of nerves immunoreactive for each antigen were quantified and analysed statistically. The morphology of the nerves in the diseased dogs was similar to that in controls. Only vasoactive intestinal peptide was reduced in expression in dogs (median proportion in control dogs 0.57, in diseased dogs 0.17; P = 0.065). This study demonstrates both morphological similarities and significant differences between closely related conditions in dogs, humans and other species.
    Anantomia Histologia Embryologia 07/2002; 31(3):139-43. · 0.90 Impact Factor
  • Article: Radical hysterectomy for early stage cervical cancer and resulting morbidity.
    Gynecologic Oncology 09/2001; 82(2):410-1. · 3.89 Impact Factor
  • Article: Cloning of dexamethasone-induced transcript: a novel glucocorticoid-induced gene that is upregulated in emphysema.
    [show abstract] [hide abstract]
    ABSTRACT: To identify changes in gene expression associated with emphysema, we used differential display to compare RNA extracted from emphysematous lungs with that of unused donor tissues taken at the time of transplant. A differentially expressed sequence was identified corresponding to the 3' end of a novel human complementary DNA (cDNA) of unknown function. The human and mouse cDNA sequences were completed by 5' rapid amplification of cDNA ends. We have named it DEXI for dexamethasone-induced transcript. DEXI messenger RNA (mRNA) was upregulated 147% in emphysematous tissue compared with donor tissue. DEXI mRNA was also upregulated 230% by dexamethasone treatment of A549. The increase in expression of DEXI found in emphysema patients' tissues may be owing to their known treatment with corticosteroids. The human DEXI gene is intronless and the predicted open reading frame encodes a 95-residue acidic protein. Database searches revealed the presence of homologues only in mammals, and a human pseudogene. The protein has a predicted central transmembrane domain and a carboxy-terminal leucine zipper. The human mRNA has a single 1.3-kb transcript. We suggest that the increased expression of DEXI in emphysema may either be relevant to disease progression or be indicative of glucocorticoid responsiveness in treated patients.
    American Journal of Respiratory Cell and Molecular Biology 08/2001; 25(1):119-24. · 5.13 Impact Factor
  • Article: Superoxide dismutase in development of obliterative bronchiolitis.
    Transplantation Proceedings 07/2001; 33(4):2477. · 1.00 Impact Factor
  • Article: Pantoprazole therapy in the long-term management of severe acid peptic disease: clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies.
    [show abstract] [hide abstract]
    ABSTRACT: Pantoprazole is the third proton pump inhibitor to become available. When this study was started, there were few data on its long-term use. Our aim was to investigate this aspect and, because powerful inhibitors of acid secretion can cause hypergastrinemia and, in experimental animals, enterochromaffin-like cell hyperplasia, we also monitored serum gastrin and endocrine cell histology. One hundred fifty patients refractory to H2-receptor antagonists, running an aggressive course or with complications, were entered into a 5-yr treatment program. We performed serial endoscopy, checked for adverse events, and laboratory values. We also monitored serum gastrin, gastric endocrine cell histology, and antral and corpus gastritis. This report presents results from up to 3 yr of treatment. Cumulative healing on 40-80 mg of pantoprazole was 82% at 4 wk and 92% by 12 wk. Most patients became asymptomatic within 4 wk. Remission on maintenance treatment with 40 mg (n = 111) was 85% at 12 months and 78% at 24 months. Treatment was safe; only four patients had adverse events definitely related to pantoprazole. Elevations in gastrin were modest and there were no significant changes in gastric endocrine cells. The number of enterochromaffin-like cells tended to decrease. Pantoprazole is effective, safe, and does not seem to be associated with large increases in serum gastrin or alterations in gastric endocrine cells.
    The American Journal of Gastroenterology 07/2001; 96(6):1767-76. · 7.28 Impact Factor

Institutions

  • 2009
    • Orton Orthopaedic Hospital
      Helsinki, Province of Southern Finland, Finland
  • 1996–2008
    • Imperial College London
      • • Department of Materials
      • • Faculty of Medicine
      • • Tissue Engineering and Regenerative Medicine Centre (TERM)
      • • Centre for Pathology
      London, ENG, United Kingdom
  • 2001–2004
    • Chelsea and Westminster Hospital NHS Foundation Trust
      London, ENG, United Kingdom
  • 1995–2001
    • Southampton University Hospitals NHS
      Southampton, ENG, United Kingdom
  • 1991–1999
    • National Heart, Lung, and Blood Institute
      Bethesda, MD, USA
    • Università degli Studi di Torino
      • Dipartimento di Scienze Veterinarie
      Torino, Piedmont, Italy
    • McGill University
      • Department of Pathology
      Montréal, Quebec, Canada
    • Naval Postgraduate School
      • Department of Histochemistry
      Monterey, CA, USA
  • 1988–1998
    • University College London
      • Department of Cell and Developmental Biology
      London, ENG, United Kingdom
    • Royal Free London NHS
      London, ENG, United Kingdom
    • University of Rome Tor Vergata
      Roma, Latium, Italy
  • 1984–1998
    • Ealing, Hammersmith & West London College
      London, ENG, United Kingdom
  • 1990–1997
    • Helsinki University Central Hospital
      • Department of Orthopaedics and Traumatology
      Helsinki, Province of Southern Finland, Finland
    • Università degli studi di Pavia
      Pavia, Lombardy, Italy
    • Papworth Hospital NHS Foundation Trust
      Papworth Everard, ENG, United Kingdom
    • Universidad de Pamplona
      Pamplona, Departamento de Norte de Santander, Colombia
    • Kingston College United Kingdom
      London, ENG, United Kingdom
  • 1991–1996
    • University of Helsinki
      • Department of Anatomy
      Helsinki, Province of Southern Finland, Finland
  • 1993–1995
    • Università degli Studi dell'Aquila
      • SS in Internal Medicine
      L’Aquila, Abruzzo, Italy
    • ICL
      London, ENG, United Kingdom
  • 1970–1995
    • Lund University
      • Department of Pathology
      Lund, Skane, Sweden
  • 1994
    • University College London Hospitals
      London, ENG, United Kingdom
    • Università degli Studi di Napoli Federico II
      Portici, Campania, Italy
  • 1993–1994
    • Universidad de Navarra
      • School of Sciences
      Pamplona, Navarre, Spain
  • 1991–1994
    • Middlesex University, UK
      London, ENG, United Kingdom
  • 1989–1993
    • North Middlesex University Hospital
      London, ENG, United Kingdom
    • Institute for Child Health Policy (ICHP)
      • Institute of Child Health
      London, OH, USA
    • Second University of Naples
      • Faculty of Medicine and Surgery
      Napoli, Campania, Italy
    • University of Leeds
      Leeds, ENG, United Kingdom
    • Universität Innsbruck
      Innsbruck, Tyrol, Austria
  • 1992
    • State University of New York Downstate Medical Center
      Brooklyn, NY, USA
  • 1987
    • Victoria General Hospital
      Winnipeg, Manitoba, Canada
  • 1982
    • University of Bologna
      Bologna, Emilia-Romagna, Italy
    • The Institute of Mental Health
      Hammersmith, ENG, United Kingdom